XML 16 R10.htm IDEA: XBRL DOCUMENT
v3.20.1

Fixed Assets | 6 Months Ended
--- | ---
Dec. 31, 2019
Property, Plant and Equipment [Abstract] |
FIXED ASSETS | NOTE 4 - FIXED ASSETS Fixed assets consisted of the following (rounded to nearest $00):
|  | Useful lives |  | December 31, 2019 |  |  | June 30, 2019 |  |  | June 30, 2018 |
Computer and software |  | 3 years |  | $ | 16,700 |  |  | $ | 16,700 |  |  | $ | 16,700 |
Less: accumulated depreciation |  |  |  |  | (11,700 | ) |  |  | (9,500 | ) |  |  | (4,600 | )
Fixed assets, net |  |  |  | $ | 5,000 |  |  | $ | 7,200 |  |  | $ | 12,100 |
In June 2015, the Company entered into an Agreement of Lease (the Lease) for office space located at 275 Madison Avenue, 7th Floor, New York, New York 10016, its former corporate headquarter, with a third party. On March 10, 2016 and effective as of January 1, 2016, the Company entered into an Office Space License Agreement (the License) with Actinium Pharmaceuticals, Inc. (Actinium), with whom the Company shared two common board members until June 6, 2017, for the office space. The term of the License was three years from the effective date, with an automatic renewal provision. The cost of the License was approximately $16,600 per month for Actinium, subject to customary escalations and adjustments. The Company recorded the license fees as other income in the consolidated statements of operations. On June 8, 2017, the Company entered into an Amended and Restated License Agreement with Actinium. Pursuant to the terms of the agreement, Actinium will continue to license the furniture, fixtures, equipment and tenant improvements located in the office (FFE) for a license fee of $7,529 per month until December 8, 2022. Actinium shall have at any time during the term of this agreement the right to purchase the FFE for $496,914, less any previously paid license fees. The license of FFE qualifies as a sales-type lease. On June 8, 2017 the Company derecognized the underlying assets of $493,452, recognized discounted lease payments receivable of $397,049 using the discount rate of 8.38% and recognized loss on sales-type lease of fixed assets of $96,403. As of December 31, 2019, June 30, 2019 and June 30, 2018, the balance of unearned interest income was approximately $32,100, $43,000 and 68,800 respectively. The future minimum lease payments to be received under the lease for each of the fiscal years as of December 31, 2019 are as follows:
2020 |  | $ | 90,348 |
2021 |  |  | 90,348 |
2022 |  |  | 90,348 |
Total |  | $ | 271,044 |

X
- References No definition available. + Details
Name: | us-gaap_PropertyPlantAndEquipmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI http://asc.fasb.org/topic&trid=2155823 + Details
Name: | us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration